Register for our free email digests:
Latest From Asahi Kasei Corp.
This week's Pipeline Watch, a snapshot of all the late-stage R&D and regulatory events in the pharma and biotech industries, is now available to view.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced August-September 2015.
Q4 device financing reached $902 million versus Q3’s $734 million, while device M&A dollar volume increased $19 billion, from Q3’s $4.9 billion. Diagnostics companies raised $750 million, an 85% rise over the previous quarter’s $405 million; although diagnostics M&A totaled just $1 billion, it was the most deal-active quarter of 2014 with 11 transactions.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced January-February 2015.
- Diagnostic Equipment & Supplies
- Radiofrequency Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Radiopharmaceuticals, Contrast Agents
- Therapeutic Areas
- Renal System
- North America
- Parent & Subsidiaries
- AngioDynamics Inc.
- Senior Management
James Clemmer, Pres. & CEO
Michael Greiner, EVP, CFO
- Contact Info
Phone: (518) 795-1400
14 Plaza Dr.
Latham, NY 12110
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.